2020
DOI: 10.25259/sni_466_2020
|View full text |Cite
|
Sign up to set email alerts
|

Aneurysmal bone cyst of thoracic spine with neurological deficit and its recurrence treated with multimodal intervention – A case report

Abstract: Background: Aneurysmal bone cysts (ABCs) are rare, representing about 1% of primary bone tumors, and 15% of all primary spine/sacral tumors. Notably, when they are located in poorly accessible regions such as the spine and pelvis, their management may be challenging. Treatment options include selective arterial embolization (SAE), curettage, en bloc excision with reconstruction, and radiotherapy. Case Description: A 16-year-old male presented with 2 months of mid back pain, left-sided thoracic radiculopath… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0
1

Year Published

2022
2022
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 21 publications
0
1
0
1
Order By: Relevance
“…However, rapid growth and expansion are associated with pain, as well as neurological deficits due to compression of adjacent tissue. 6 This patient did not have any neurological deficits at the time of presentation; however, the lesion did grow rapidly. The patient urgently made an appointment with his pediatrician after he noticed the “growing bump” in his scalp.…”
Section: Discussionmentioning
confidence: 77%
“…However, rapid growth and expansion are associated with pain, as well as neurological deficits due to compression of adjacent tissue. 6 This patient did not have any neurological deficits at the time of presentation; however, the lesion did grow rapidly. The patient urgently made an appointment with his pediatrician after he noticed the “growing bump” in his scalp.…”
Section: Discussionmentioning
confidence: 77%
“…Considerar siempre la estabilización quirúrgica si se desarrolla una deformidad posoperatoria o por el grado de resección ósea. 16 La radioterapia como opción queda hoy reservada para pacientes con alto riesgo de no tolerar una cirugía o para aquellos que no responden al tratamiento quirúrgico, más aún considerando los riesgos potenciales de mielopatía posradiación o transformación sarcomatosa. 17,18 Dentro de las opciones de quimioterapia, se menciona el denosumab, un anticuerpo monoclonal humano que se une al activador del receptor de citocinas del ligando del factor nuclear kappa B.…”
Section: Discussionunclassified